Skip to main content
. Author manuscript; available in PMC: 2014 Jun 11.
Published in final edited form as: J Thorac Oncol. 2010 Feb;5(2):275–279. doi: 10.1097/JTO.0b013e3181c5e366

FIGURE 2.

FIGURE 2

Study design for phase III trial comparing vorinostat versus placebo in patients with previously treated malignant pleural mesothelioma (MPM).